Hologic CFO Awarded RSUs, Sells Shares for Tax Obligations
HOLOGIC INC
Subscribe to track HOLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Hologic CFO Awarded RSUs, Sells Shares for Tax Obligations
Company: HOLOGIC INC (HOLX) Form: 4 | Filed: 2025-11-12 Significance: Low
Insider: Oberton Karleen Marie Title: Chief Financial Officer | Relationship: Officer
Transaction (Primary): • Type: Grant (RSU Award) • Shares: 43,741 • Price: $0.00 • Value: $0 (Notional value ~$3.26M) • Owned After: 152,068
Key Insight: The CFO received a routine RSU grant as part of her compensation. Subsequent sales were automatic dispositions to cover tax liabilities from vesting units and are not discretionary trades.
Market Context: These transactions are standard executive compensation events and have a negligible impact on Hologic's $16.54 billion market capitalization.
Comprehensive Analysis
SEC Filing Analysis: HOLOGIC INC (HOLX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Hologic's CFO, Karleen Marie Oberton, received a routine grant of 43,741 Restricted Stock Units (RSUs) and subsequently disposed of a total of 10,876 shares in non-discretionary transactions to cover tax obligations.
- Market Impact: Negligible. These are standard, non-discretionary compensation events that do not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | HOLOGIC INC |
| Ticker Symbol | HOLX |
| CIK | 0000859737 |
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
Insider Information
| Field | Value |
|---|---|
| Name | Oberton Karleen Marie |
| CIK | 0001314036 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
This filing reports three transactions: one RSU grant and two tax-related dispositions. The primary event is the RSU grant.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-10 |
| Transaction Code | A (Grant) |
| Security Type | Common Stock (as RSUs) |
| Shares Involved | 43,741 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 152,068 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
The analysis focuses on the RSU grant, which is the most significant component of the filing.
| Metric | Value |
|---|---|
| Transaction Value | $0 (Notional value of grant: ~$3.26M based on recent trading prices) |
| % of Market Cap | ~0.02% (based on notional value) |
| Shares Transacted | 43,741 |
| % of Shares Outstanding | 0.0197% |
| Post-Transaction Ownership | 152,068 shares (0.068% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The grant's notional value is insignificant relative to Hologic's $16.54 billion market capitalization.
- Ownership Concentration: The CFO's total holdings remain a very small fraction of the company's total shares outstanding.
- Dilution Impact: The 43,741 new RSUs represent a minimal potential dilution of approximately 0.02% for existing shareholders, which is a standard part of executive compensation programs.
- Transaction Significance: The transactions are low significance. The grant is a routine compensation event, and the sales (Code 'F') are automatic withholdings to satisfy tax liabilities, not discretionary market sales.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing details standard executive compensation activities. The dispositions are non-discretionary tax-related events, which do not reflect the insider's sentiment about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. The transactions are not open-market trades that would affect trading volume.
- Sentiment Indicator: Neutral. This filing is informational regarding executive compensation and does not provide a bullish or bearish signal.
Additional Context
Transaction Notes
- The filing documents an award of RSUs (Code 'A') and two separate dispositions (Code 'F') to cover tax obligations from vesting equity. As noted in footnote F1, these are not discretionary sales but are required withholdings.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
